Artykuły w czasopismach na temat „RSA advisors/referents”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „RSA advisors/referents”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Carande, Robert. "Reference Advisory Systems (RAS): Some Practical Issues". Reference Services Review 17, nr 3 (marzec 1989): 87–90. http://dx.doi.org/10.1108/eb049069.
Pełny tekst źródłaAmbrogi, Federica. "Elisa Paini (1863-1924). Wife and «unbeatable collaborator» of Luigi Credaro". Rivista di Storia dell’Educazione 7, nr 2 (4.12.2020): 133–44. http://dx.doi.org/10.36253/rse-9865.
Pełny tekst źródłaWalker, Christopher J., Junke Wang, Alyssa I. Clay-Gilmour, Krzysztof Mrózek, Deedra Nicolet, Christopher C. Oakes, Jessica Kohlschmidt i in. "Meta-Analysis of Genome-Wide Association Studies of Acute Myeloid Leukemia (AML) Patients Identifies Variants Associated with Risk of 11q23/KMT2A-Translocated and Core-Binding Factor (CBF) AML and Suggests a Role for Transcription Elongation in Leukemogenesis". Blood 136, Supplement 1 (5.11.2020): 29–30. http://dx.doi.org/10.1182/blood-2020-141653.
Pełny tekst źródłaVisconte, Valeria, Bartlomiej P. Przychodzen, Vera Adema, Cassandra M. Hirsch, Allison Noe, Rachel Toth, Christina Snider i in. "Development of a Novel Class of Agents Targeting the RNA-Splicing Machinery in Myeloid Malignancies". Blood 132, Supplement 1 (29.11.2018): 211. http://dx.doi.org/10.1182/blood-2018-99-116411.
Pełny tekst źródłaYalniz, Fevzi F., Rima M. Saliba, Orhan K. Yucel, Guillermo Garcia-Manero, Jeremy Ramdial, Uday Popat, Stefan O. Ciurea i in. "Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation". Blood 134, Supplement_1 (13.11.2019): 512. http://dx.doi.org/10.1182/blood-2019-125937.
Pełny tekst źródłaMurphy, Tracy, Stanley W. K. Ng, Tong Zhang, Ian King, Andrea Arruda, Jaime O. Claudio, Narmin Ibrahimova i in. "Trial in Progress: Feasibility and Validation Study of the LSC17 Score in Acute Myeloid Leukemia Patients". Blood 134, Supplement_1 (13.11.2019): 2682. http://dx.doi.org/10.1182/blood-2019-130532.
Pełny tekst źródłaMahevas, Matthieu, Stephanie Guillet, Jean-Francois Viallard, Delphine Gobert, Marion Malphettes, Stephane Cheze, Francois Lefrere i in. "Rate of Prolonged Response after Stopping Thrombopoietin-Receptor Agonists Treatment in Primary Immune Thrombocytopenia (ITP): Results from a Nationwide Prospective Multicenter Interventional Study (STOPAGO)". Blood 138, Supplement 1 (5.11.2021): 583. http://dx.doi.org/10.1182/blood-2021-152767.
Pełny tekst źródłaTomaz, Victória, Karina Griesi-Oliveira, Renato D. Puga, Fabio Pires de Souza Santos, Nelson Hamerschlak i Paulo Vidal Campregher. "Identification of Gene Networks Associated with the Anti-Leukemic Effect of Anti-Inflammatory Drugs on Acute Myeloid Leukemia Cell Lines". Blood 138, Supplement 1 (5.11.2021): 4343. http://dx.doi.org/10.1182/blood-2021-153903.
Pełny tekst źródłaPerumal, Deepak, Alessandro Lagana', Alex Rubinsteyn, John P. Finnigan, Pei-Yu Kuo, Violetta V. Leshchenko, Ajai Chari i in. "Patient-Specific Mutation-Derived Tumor Antigens As Targets for Cancer Immunotherapy in Multiple Myeloma". Blood 126, nr 23 (3.12.2015): 1851. http://dx.doi.org/10.1182/blood.v126.23.1851.1851.
Pełny tekst źródłaYao, Lijun, Reyka G. Jayasinghe, Beena E. Thomas, Swati S. Bhasin, Nicolas Fernandez, Taxiarchis Kourelis, Deon Doxie i in. "Integrated Cytof, Scrna-Seq and Cite-Seq Analysis of Bone Marrow Immune Microenvironment in the Mmrf Commpass Study". Blood 136, Supplement 1 (5.11.2020): 28–29. http://dx.doi.org/10.1182/blood-2020-142534.
Pełny tekst źródłaPelham, Robert J., Xuguang Hu, Philippe Moreau, Albert Oriol, Hang Quach, Tibor Kovacsovics, Jonathan J. Keats, Shibao Feng, Amy S. Kimball i Meletios A. Dimopoulos. "Genomic Predictors of Progression-Free Survival Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Carfilzomib and Dexamethasone or Bortezomib and Dexamethasone in the Phase 3 Endeavor Trial". Blood 130, Suppl_1 (7.12.2017): 839. http://dx.doi.org/10.1182/blood.v130.suppl_1.839.839.
Pełny tekst źródłaMageau, Arthur, Louis Terriou, Mikael Ebbo, Odile Souchaud-Debouverie, Corentin Orvain, Julie Graveleau, Jean-Christophe Lega i in. "Splenectomy for Primary Immune Thrombocytopenia Revisited at the Era of Thrombopoietin Receptor Agonists: New Insights for an Old Treatment". Blood 138, Supplement 1 (5.11.2021): 17. http://dx.doi.org/10.1182/blood-2021-147450.
Pełny tekst źródłaBrummaier, Tobias, Basirudeen Syed Ahamed Kabeer, Stephen Lindow, Justin C. Konje, Sasithon Pukrittayaamee, Juerg Utzinger, Mohammed Toufiq i in. "A prospective cohort for the investigation of alteration in temporal transcriptional and microbiome trajectories preceding preterm birth: a study protocol". BMJ Open 9, nr 1 (styczeń 2019): e023417. http://dx.doi.org/10.1136/bmjopen-2018-023417.
Pełny tekst źródłaCroucher, Danielle C., Marta Chesi, Zhihua Li, Victoria Marie Garbitt, Meaghen E. Sharik, Daniel Waller, Michael Sebag, P. Leif Bergsagel, Trevor J. Pugh i Suzanne Trudel. "A Single-Cell Transcriptional Analysis of Tumour Cells and the Immune Microenvironment during Disease Evolution in a Transgenic Mouse Model of Myeloma". Blood 132, Supplement 1 (29.11.2018): 56. http://dx.doi.org/10.1182/blood-2018-99-118691.
Pełny tekst źródłaNicolini, Franck E., Vincent Alcazer, Stephanie Dulucq, Sandrine Hayette, Jean-Michel Cayuela, Stephane Morisset, Christophe Bouvier, Francois-Xavier Mahon, Gabriel Etienne i Delphine Rea. "The Outcome of Treatment-Free Remission after First-Line Nilotinib or Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients Is Different". Blood 138, Supplement 1 (5.11.2021): 2552. http://dx.doi.org/10.1182/blood-2021-146722.
Pełny tekst źródłaRoeser, Anais, Guillaume Moulis, Mikael Ebbo, Louis Terriou, Elsa Poullot, Bertrand Lioger, Marie Chilles i in. "A Retrospective Multicenter Case Study Evaluating the Characteristics, Management and Outcome of Acquired Amegakaryocytic Thrombocytopenia". Blood 138, Supplement 1 (5.11.2021): 3167. http://dx.doi.org/10.1182/blood-2021-153388.
Pełny tekst źródłaBloehdorn, Johannes, Julia Krzykalla, Billy Michael Chelliah Jebaraj, Karlheinz Holzmann, Jasmin Bahlo, Sandra Robrecht, Kathryn Humphrey i in. "MYC Pathway Activation Is Frequently Observed in Treatment-Naive CLL and Defines a Subgroup with Particular Benefit from the Addition of Rituximab to Chemotherapy". Blood 132, Supplement 1 (29.11.2018): 1866. http://dx.doi.org/10.1182/blood-2018-99-116937.
Pełny tekst źródłaFulciniti, Mariateresa, Charles Y. Lin, Mehmet K. Samur, Matthew Lawlor, Kenneth C. Anderson, James E. Bradner i Nikhil C. Munshi. "Discovery and Characterization of Promoter and Super-Enhancer-Associated Dependencies through E2F and BET Bromodomains in Multiple Myeloma". Blood 126, nr 23 (3.12.2015): 838. http://dx.doi.org/10.1182/blood.v126.23.838.838.
Pełny tekst źródłavan Beers, Erik H., Martin H. Van Vliet, Kenneth C. Anderson, Ajai Chari, Sundar Jagannath, Andrzej Jakubowiak, Shaji K. Kumar i in. "High Risk Multiple Myeloma Cases Are Identified In An MMRC Led Study By The SKY92 Gene Signature (MMprofiler)". Blood 122, nr 21 (15.11.2013): 1854. http://dx.doi.org/10.1182/blood.v122.21.1854.1854.
Pełny tekst źródłaAsmann, Yan, Ying Li, Taxiarchis Kourelis, Moritz Binder, Wilson I. Gonsalves, Henan Zhang, Anatilde Gonzalez Guerrico i in. "Single Cell Transcriptome Profile of Myeloma and Immune Cell Characteristics in Patients with Durable Response Post CART". Blood 138, Supplement 1 (5.11.2021): 3838. http://dx.doi.org/10.1182/blood-2021-153254.
Pełny tekst źródłaMurphy, Tracy, Stanley W. K. Ng, Ian King, Tong Zhang, Andrea Arruda, Narmin Ibrahimova, Jaime O. Claudio i in. "Inferior Outcomes with a High LSC17 Score Can be Improved with Flag-IDA". Blood 136, Supplement 1 (5.11.2020): 35–36. http://dx.doi.org/10.1182/blood-2020-138943.
Pełny tekst źródłaCatalano, Calogerina, Joanna Blocka, Stefanie Huhn, Nagarajan Paramasivam, Matthias Schlesner, Niels Weinhold, Rolf Sijmons i in. "Characterization of Rare Germline Variants in Familial Multiple Myeloma". Blood 136, Supplement 1 (5.11.2020): 45–46. http://dx.doi.org/10.1182/blood-2020-142253.
Pełny tekst źródłaTirier, Stephan M., Jan-Philipp Mallm, Nicola Casiraghi, Hana Susak, Nicola Giesen, Alexandra M. Poos, Katharina Bauer i in. "Dissecting Heterogeneity of Tumor Cells and Their Microenvironment in Refractory Multiple Myeloma". Blood 134, Supplement_1 (13.11.2019): 571. http://dx.doi.org/10.1182/blood-2019-128625.
Pełny tekst źródłaMaeding, Nicole, Daniela Asslaber, Nadja Zaborsky, Andreas Villunger, Richard Greil i Alexander Egle. "Lack of Bmf Facilitates the Selection of Highly Responsive B-Cell Receptor Clones in Chronic Lymphocytic Leukemia". Blood 138, Supplement 1 (5.11.2021): 1543. http://dx.doi.org/10.1182/blood-2021-152216.
Pełny tekst źródłaGarg, Tarun K., Ricky D. Edmondson, Shweta S. Chavan, Katie Stone, Justin M. Stivers, Jessica I. Warden, Veronica Macleod i in. "Differential ICAM3 Gene Expression Correlates with Susceptibility to Natural Killer Cell-Mediated Lysis in Multiple Myeloma". Blood 126, nr 23 (3.12.2015): 2990. http://dx.doi.org/10.1182/blood.v126.23.2990.2990.
Pełny tekst źródłaMehr, Shaadi, Daniel Auclair, Mark Hamilton, Leon Rozenblit, Hearn Jay Cho, Lijun Yao, Reyka G. Jayasinghe i in. "Architecture of Sample Preparation and Data Governance of Immuno-Genomic Data Collected from Bone Marrow and Peripheral Blood Samples Obtained from Multiple Myeloma Patients". Blood 136, Supplement 1 (5.11.2020): 17–18. http://dx.doi.org/10.1182/blood-2020-142882.
Pełny tekst źródłaTarantino, Michael D., Michael Vredenburg, Wei Tian, Brian Jamieson i Kashyap B. Patel. "Efficacy Analyses from the Immune Thrombocytopenia (ITP) Clinical Development Program for Avatrombopag: Comparisons with Placebo and Eltrombopag". Blood 136, Supplement 1 (5.11.2020): 23–24. http://dx.doi.org/10.1182/blood-2020-142788.
Pełny tekst źródłaWhite, Brian S., Suleiman A. Khan, Muhammad Ammad-ud-din, Swapnil Potdar, Mike J. Mason, Cristina E. Tognon, Brian J. Druker i in. "Comparative Analysis of Independent Ex Vivo functional Drug Screens Identifies Predictive Biomarkers of BCL-2 Inhibitor Response in AML". Blood 132, Supplement 1 (29.11.2018): 2763. http://dx.doi.org/10.1182/blood-2018-99-111916.
Pełny tekst źródłaMishima, Yuji, Michele Moschetta, Jiantao Shi, Francois Mercier, Salomon Manier, Siobhan Glavey, Michaela R. Reagan i in. "Clonal-Heterogeneity and Propensity for Bone Metastasis in Multiple Myeloma". Blood 124, nr 21 (6.12.2014): 3370. http://dx.doi.org/10.1182/blood.v124.21.3370.3370.
Pełny tekst źródłaWang, Tianjiao, Hua Sun, Daniel Cui Zhou, Ruiyang Liu, Lijun Yao, Mark A. Fiala, Daniel R. Kohnen i in. "Single-Cell Pathway Enrichment and Regulatory Profiling of Multiple Myeloma across Disease Stages". Blood 134, Supplement_1 (13.11.2019): 364. http://dx.doi.org/10.1182/blood-2019-131361.
Pełny tekst źródłaSpencer, Andrew, Tiffany Khong i Maoshan Chenn. "MCL-1 Inhibitor-Induced Killing of Multiple Myeloma Is Modulated By the Relative Level of Expression of Pro-Survival Members of the BCL-2 Family and the Proto-Oncogene MYC". Blood 134, Supplement_1 (13.11.2019): 1825. http://dx.doi.org/10.1182/blood-2019-127843.
Pełny tekst źródłaMatino, Davide, Giancarlo Castaman, Giovanni Di Minno, Paola Giordano, Maria Elisa Mancuso, Emanuela Marchesini, Flora Peyvandi i in. "Prospective Study of the Immunological Mechanisms of Immune Tolerance Induction in Severe Haemophilia a Patients with Inhibitors: Preliminary Analysis of a Multi-Center Longitudinal Study". Blood 132, Supplement 1 (29.11.2018): 3781. http://dx.doi.org/10.1182/blood-2018-99-119568.
Pełny tekst źródłaWallace, Sarah, Victoria Hall, Andre Charlett, Peter D. Kirwan, Michele Cole, Natalie Gillson, Ana Atti i in. "Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers – the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol". BMJ Open 12, nr 6 (czerwiec 2022): e054336. http://dx.doi.org/10.1136/bmjopen-2021-054336.
Pełny tekst źródłaLee, Shawn, Federico Antillón, Deqing Pei, Wenjian Yang, Kathryn G. Roberts, Zhenhua Li, Meenakshi Devidas i in. "The Impact of Genetic Ancestry on the Biology and Prognosis of Childhood Acute Lymphoblastic Leukemia". Blood 138, Supplement 1 (5.11.2021): 3476. http://dx.doi.org/10.1182/blood-2021-145655.
Pełny tekst źródłaSauer, Sandra, Christos Sachpekidis, Simone Brandelik, Daniel Spira, Stefanie Huhn, Barbara Wagner, Manuela Hummel i in. "Prospective Evaluation of 18-F FDG PET/CT and Biopsies of Osteolytic Lesions and Random Bone Marrow Samples in Newly Diagnosed Multiple Myeloma Patients". Blood 132, Supplement 1 (29.11.2018): 3180. http://dx.doi.org/10.1182/blood-2018-99-115201.
Pełny tekst źródłaRoter, Kyle, Donglei Hu, Alyssa Clay-Gilmour, Scott Huntsman, Nina D. Shah, Sandy W. Wong, Thomas G. Martin i in. "Germline Variation Predicts Treatment Response in Multiple Myeloma". Blood 134, Supplement_1 (13.11.2019): 4397. http://dx.doi.org/10.1182/blood-2019-129344.
Pełny tekst źródłaPoos, Alexandra M., Jan-Philipp Mallm, Stephan M. Tirier, Nicola Casiraghi, Hana Susak, Nicola Giesen, Katharina Bauer i in. "A Comprehensive Analysis of Single-Cell Chromatin Accessibility and Gene Expression Identifies Intra-Tumor Heterogeneity and Molecular Treatment Responses in Relapsed/Refractory Multiple Myeloma". Blood 134, Supplement_1 (13.11.2019): 575. http://dx.doi.org/10.1182/blood-2019-130051.
Pełny tekst źródłaCoffey, David G., Francesco Maura, Edgar Gonzalez-Kozlova, Javier Diaz-Mejia3, Ping Luo, Yong Zhang, Yuexin Xu i in. "Normalization of the Immune Microenvironment during Lenalidomide Maintenance Is Associated with Sustained MRD Negativity in Patients with Multiple Myeloma". Blood 138, Supplement 1 (5.11.2021): 329. http://dx.doi.org/10.1182/blood-2021-154506.
Pełny tekst źródłaSheih, Alyssa, Jonathan L. Golob, Abir Bhattacharyya, Michael C. Wu, Aesha Vakil, Sujatha Srinivasan, Steven A. Pergam, David N. Fredricks i Cameron J. Turtle. "Impact of Intestinal Microbiota on Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Stem Cell Transplantation". Blood 132, Supplement 1 (29.11.2018): 3393. http://dx.doi.org/10.1182/blood-2018-99-115158.
Pełny tekst źródłaMcCarthy, John J. "Alan S. Kaye (ed.) (1997). Phonologies of Asia and Africa (including the Caucasus). Technical advisor: Peter T. Daniels. Winona Lake, Indiana: Eisenbrauns. 2 vols. Pp. xxi+1041." Phonology 15, nr 1 (sierpień 1998): 111–14. http://dx.doi.org/10.1017/s0952675798003509.
Pełny tekst źródłaArkian, Muhammad Reyzha Noorsyam, M. Subur Drajat i Dadi Ahmadi. "Peran Public Relations dalam Film Hancock". Inter Komunika : Jurnal Komunikasi 3, nr 2 (11.12.2018): 145. http://dx.doi.org/10.33376/ik.v3i2.214.
Pełny tekst źródłaDecroocq, Justine, Rudy Birsen, Jordi Mano, Guillemette Fouquet, Mathilde Gotanègre, Laury Poulain, Sarah Mouche i in. "Combination of the MEK Inhibitor Trametinib and Pyrvinium Pamoate Efficiently Targets RAS Pathway-Mutated Acute Myeloid Leukemia in Preclinical Models". Blood 134, Supplement_1 (13.11.2019): 2671. http://dx.doi.org/10.1182/blood-2019-123418.
Pełny tekst źródłaZhang, Haiyu, Bing Zhang, Xiangqian Guo, Naznin Haq, Robert B. West, James B. Bussel i James L. Zehnder. "Effects of Thrombopoietin Mimetics on Patients with Chronic ITP: Perspectives from Blood Transcriptome Profiling Analysis". Blood 124, nr 21 (6.12.2014): 2780. http://dx.doi.org/10.1182/blood.v124.21.2780.2780.
Pełny tekst źródłaBai, Xiaoying, Jennifer Trowbridge, Joseph Lee, Stuart H. Orkin i Leonard I. Zon. "Analysis of TIF1gamma Conditional Knockout Establishes a Requirement for the Differentiation of Multiple Hematopoietic Lineages". Blood 116, nr 21 (19.11.2010): 744. http://dx.doi.org/10.1182/blood.v116.21.744.744.
Pełny tekst źródłaSharma, Priyanka, Sujan Piya, Huaxian Ma, Natalia Baran, Malgorzata Anna Zal, Christopher J. Hindley, Kim-Hien Dao i in. "ERK1/2 Inhibition Overcomes Resistance in Acute Myeloid Leukemia (AML) and Alters Mitochondrial Dynamics". Blood 138, Supplement 1 (5.11.2021): 3338. http://dx.doi.org/10.1182/blood-2021-151579.
Pełny tekst źródłaStahlberg, Eric, Lynn Borkon, Ruth Frost, Sara Jones, Amar Khalsa, Lauren Lewis, Emily Greenspan i Sunita Menon. "Abstract 7432: Improving FAIRness of computational approaches for cancer: The computational resources for cancer research portal". Cancer Research 84, nr 6_Supplement (22.03.2024): 7432. http://dx.doi.org/10.1158/1538-7445.am2024-7432.
Pełny tekst źródłaKumar, Ashwini, Muntasir Mamun Majumder, Jesus María Lopez Martí, Alun Parsons, Pirkko Mattila, Kimmo Porkka, Olli Kallioniemi i Caroline A. Heckman. "The Use of RNA Sequencing to Identify Disease-Specific Gene Expression Signatures and Critical Regulatory Networks Across Hematologic Malignancies". Blood 124, nr 21 (6.12.2014): 2203. http://dx.doi.org/10.1182/blood.v124.21.2203.2203.
Pełny tekst źródłaChen, Zhenghao, Gaspard Cretenet, Beatriz Valle-Argos, Francesco Forconi, Arnon P. Kater, Graham Packham i Eric Eldering. "Effects of Ibrutinib on Metabolic Alterations and Micro-Environmental Signalling in Chronic Lymphocytic Leukaemia". Blood 136, Supplement 1 (5.11.2020): 36–37. http://dx.doi.org/10.1182/blood-2020-142839.
Pełny tekst źródłaClarke, Stanley R., Adrianna Vlachos, Jens Lichtenberg, Nancy E. Seidel, Jaya Jagadeesh, NISC Comparative SequencingProgram, Adam M. Phillippy i in. "Whole Genome Sequencing of Diamond Blackfan Anemia Syndrome Patients Detects Mutations That Alter mRNA Splicing". Blood 138, Supplement 1 (5.11.2021): 863. http://dx.doi.org/10.1182/blood-2021-145622.
Pełny tekst źródłaSu, Christopher T., Liying Chen, Jason Chen, Brian Parkin, Avery Polk, Malathi Kandarpa, Craig E. Cole i in. "Role of Aneuploidy in Transcriptional Regulation and Clinical Prognosis in Relapsed and/or Refractory Multiple Myeloma (RRMM)". Blood 136, Supplement 1 (5.11.2020): 45–46. http://dx.doi.org/10.1182/blood-2020-134558.
Pełny tekst źródła